| mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
2e-07 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-05 |
| mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
| mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |